Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains
- 5 January 2007
- Vol. 25 (3) , 466-480
- https://doi.org/10.1016/j.vaccine.2006.07.052
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Epitope-Specific Regulation of Immunoglobulin Class Switching in Mice Immunized with Malarial Merozoite Surface ProteinsInfection and Immunity, 2005
- Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspAJournal of Molecular Biology, 2005
- Borreliacidal OspC Antibodies Specific for a Highly Conserved Epitope Are Immunodominant in Human Lyme Disease and Do Not Occur in Mice or HamstersClinical and Vaccine Immunology, 2005
- Multicomponent Lyme vaccine: Three is not a crowdVaccine, 2005
- Elucidation of Lyme arthritisNature Reviews Immunology, 2004
- C-Terminal Region of Outer Surface Protein C Binds Borreliacidal Antibodies in Sera from Patients with Lyme DiseaseClinical and Vaccine Immunology, 2003
- The Cost Effectiveness of Vaccinating against Lyme DiseaseEmerging Infectious Diseases, 1999
- Tick factors andin vitro cultivation influence the protein profile, antigenicity and pathogenicity of a clonedBorrelia garinii isolate fromIxodes ricinus hemolymphInfection, 1996
- Improvements in protein secondary structure prediction by an enhanced neural networkJournal of Molecular Biology, 1990
- Spirochetes Isolated from the Blood of Two Patients with Lyme DiseaseNew England Journal of Medicine, 1983